Historical overview of prion diseases: A view from afar

Folia Neuropathologica

Volumn 50, Issue 1, 2012, Pages 1-12

  Liberski, Pawel P ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Kuru; Prion; Scrapie; Transmissible spongiform encephalopathies

Indexed keywords

BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; KURU; NONHUMAN; PRION DISEASE; REVIEW; SCRAPIE;

EID: 84860325535     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (125)

1. Adams DH. The nature of the scrapie agent. A review of recent progress. Pathol Biol 1970; 18: 559-577.
2. Adams DH, Bell TM. Slow viruses. Addison-Wesley Publishing Company Inc, Massachusetts 1976.
3. Aguzzi A, Kana V. Protein aggregation in neurodegeneration. In: Dickson DW, Weller RO (eds.). Neurodegeneration: The mo lecular Pathology of Dementia and Movement Disorders. 2nd ed. Wiley-Blackwell, A John Wiley & Sons, Ltd., London 2011; pp. 13-17.
4. Akowitz A, Manuelidis EE, Manuelidis L. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease. Arch Virol 1993; 130: 301-316.
5. Akowitz A, Sklaviadis T, Manuelidis L. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease. Nucleic Acids Res 1994; 22: 1101-1107. (Pubitemid 24162176)
6. Akowitz A, Sklaviadis T, Manuelidis EE, Manuelidis L. Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations. Microb Pathog 1990; 9: 33-45. (Pubitemid 20351281)
7. Alper T. The scrapie enigma: insights from radiation experiments. Rad Res 1993; 135: 283-292. (Pubitemid 23306512)
8. Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid? Nature 1967; 214: 764-776.
9. Armstrong RA. Dispersion of prion protein deposits around blood vessels in variant Creutzfeldt-Jakob disease. Folia Neuropathol 2010; 48: 150-158.
10. Barron RM, Thomson V, Jamieson E, Melton DW, Ironside J, Will R, Manson JC. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 2001; 20: 5070-5078. (Pubitemid 32910903)
11. Basler K, Oesch B, Scott M, Westaway D, Wälchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46: 417-428. (Pubitemid 16031678)
12. Bastian FO. Spiroplasma as a candidate agent for the transmissible spongiform encephalopathies. J Neuropathol Exp Neurol 2005; 64: 833-838. (Pubitemid 41434665)
13. Besnoit C. La tremblante ou nevrite peripherique enzootique du mouton. Rev Vet (Tolouse) 1899; 24: 265-277.
14. Bradley R, Collee JG, Liberski PP. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 1. Folia Neuropathol 2006; 44: 93-101. (Pubitemid 44083239)
15. Bradley R, Liberski PP. Bovine spongiform encephalopathy (BSE): the end of the beginning or the beginning of the end? Folia Neuropathol 2004; 42 Suppl A: 55-68.
16. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Koba yashi Y, Marino S, Weissmann C, Aguzzi A.Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379: 339-343. (Pubitemid 26033075)
17. Bruce ME, Dickinson AG. Biological evidence that scrapie agent has an idependent genome. J Gen Virol 1987; 68: 79-89. (Pubitemid 17207190)
18. Bruce ME, McBride PA, Farquhar CF. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci Lett 1986; 102: 1-6. (Pubitemid 19163144)
19. Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991; 72: 595-603.
20. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73: 1339-1347. (Pubitemid 23201147)
21. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356: 577-582.
22. Burger D, Hartsough GR. A scrapie-like disease of mink. In Report of a Scrapie Seminar. United States Department of Agriculture 1964; paper 27, pp. 225-227.
23. Chandler RL. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1961; 1: 1378-1379.
24. Chandler RL. Encephalopathy in mice. Lancet 1963; 1: 107-108.
25. Chandler RL. Experimental scrapie in the mouse. Res Vet Sci 1963; 4: 276-285.
26. Chandler RL. Transmissible encephalopathy in mice inoculated with scrapie brain. J Gen Microbiol 1963; 31: XIV.
27. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond SJ, Westaway D, Prusiner SB. Linkage of prion protein and scrapie incubation time genes. Cell 1986; 46: 503-511. (Pubitemid 16022406)
28. Cho HJ. Requirement of a protein component for scrapie infectivity. Intervirology 1980; 14: 213-216. (Pubitemid 11155250)
29. Colby DW, Prusiner SB. De novo generation of prion strains. Nat Rev Microbiol 2011; 9: 771-777.
30. Collee JG, Bradley R, Liberski PP. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 2. Folia Neuropathol 2006; 44: 102-110. (Pubitemid 44083240)
31. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24: 519-550. (Pubitemid 32695238)
32. Cuille J, Chelle P-L. Tremblante et louping-ill. Rev Vet (Tolouse) 1933; 85: 674-679.
33. Cuille J, Chelle P-L. La maladie dite tremblante du mouton estelle inculable? Comptes rendus des Seances de l'Academie des Sciences (Paris) 1936; 203: 1552-1554.
34. Cuille J, Chelle PL. La "tremblante" du mouton est bien inoculable. C R Acad Sci (Paris) 1938; 206: 78-79.
35. Cuille J, Chelle PL. La tremblante du mouton est-elle determine par un virus filterable? C R Acad Sci (Paris) 1938; 207: 1687-1688.
36. Cuille J, Chelle PL. La tremblante du mouton. Son etiologie. Rev Pathol Comp d'Hyg Gen 1938; 38: 1358-1372.
37. Cuille J, Chelle P-L. Transmission experimentale de la tremblante a la chevre. C R Acad Sci (Paris) 1939; 208: 1058-1060.
38. Cunningham AA, Wells GAH, Scott AC, Kirkwood JK, Barnett JEF. Transmissible spongiform encephalopathy in greater kudu (Tragelaphus strepsiceros). Vet Rec 1993; 132: 68.
39. Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425: 717-720. (Pubitemid 37314314)
40. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 2010; 49: 3928-3934.
41. Dickinson AG. Scrapie in sheep and goats. In: Kimberlin RH (ed.). Slow Virus Diseases of Animals and Man. North-Holland Publ Comp, Amsterdam 1976, pp. 209-241.
42. Dickinson AG, Fraser H, McConnell, Outram GW, Sales DI, Taylor DM. Extraneural competition between different scrapie agent leading to loss of infectivity. Nature 1975; 253: 556.
43. Dickinson AG, Fraser H, Meikle VMH, Outram GW. Competition between different scrapie agents in mice. Nature 1972; 237: 244-245.
44. Dickinson AG, Mackay JMK. Genetical control of the incubation period in mice of the neurological disease, scrapie. Heredity 1964; 19: 279-288.
45. Dickinson AG, Meikle VMH. A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet Res (Camb) 1969; 13: 213-225.
46. Dickinson AG, Meikle VMH, Fraser H. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol 1968; 78: 293-299.
47. Dickinson AG, Meikle VMH, Fraser H. Genetical control of the concentration of ME7 scrapie agent in brain of mice. J Comp Pathol 1969; 79: 15-22.
48. Dickinson AG, Outram GW. Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. In: Bock G, Marsh J (eds.). Novel infectious agents and the central nervous system. J. Wiley & Sons, Chichister 1988; pp. 63-77.
49. Dickinson AG, Outram GW. The scrapie replication-site hypothesis and its implications for pathogenesis. In: Prusiner SB, Hadlow WJ (eds.). Slow transmissible diseases of the nervous system. Vol. 2. Academic Press, New York 1979; pp. 13-31.
50. Diener TO. Is the scrapie agent a viroid? Nat New Biol 1972; 235: 218-219.
51. Diener TO. PrP and the nature of the scrapie agent. Cell 1987; 49: 719-721.
52. Diener TO, McKinley MP, Prusienr SB. Viroids and prions. Proc Natl Acad Sci USA 1982; 79: 5220-5224. (Pubitemid 12002189)
53. Diringer H, Gelderblom H, Hilmert H, Ozel M, Edelbluth C, Kimberlin RH. Scrapie infectivity, fibrils and low molecular weight protein. Nature 1983; 306: 476-478. (Pubitemid 14235568)
54. Farquhar J, Gajdusek DC eds. Kuru. Early Letters and Field-Notes from the collection of D. Carleton Gajdusek. Raven Press, New York 1981.
55. Fletwood AJ, Furley CW. Spongiform encephalopathy in an eland. Vet Rec 1990; 126: 215-222.
56. Foster JD, Dickinson AG. The unusual properties of CH1641, a sheep-passaged isolate of scrapie. Vet Rec 1988; 123: 5-8.
57. Gajdusek DC. An auto-immune reaction against human tissue antigens in certain chronic diseases. Nature 1957; 179: 666-668.
58. Gajdusek DC. Transmissible and nontransmissible dementias: distinction between primary cause and pathogenetic mechanisms in Alzheimer's disease and aging. Mount Sinai J Med 1988; 55: 3-5. (Pubitemid 18047083)
59. Gajdusek DC, Gibbs CJ. Attempts to demonstrate a transmissible agent in kuru, amyotrophic lateral sclerosis, and other subacute and chronic nervous system degenerations of man. Nature 1964; 204: 257-259.
60. Gajdusek DC, Gibbs CJ, Alpers MP. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966; 209: 794-796.
61. Gajdusek DC, Gibbs CJ, Alpers MP (eds.). Slow, Latent, and Temperate Virus Infections. U.S. Department of Health, Education, and Welfare, Public Health Service, national Institutes of Health, National Institute of Neurological Diseases and Blindness, Washin gton 1965.
62. Gibbons RA, Hunter GD. Nature of the scrapie agent. Nature 1967; 215: 1041-1043.
63. Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to chimpanzee. Science 1968; 161: 388-389.
64. Gordon WS. Louping ill, tickborne fever and scrapie. Vet Rec 1946; 47: 516-520.
65. Griffith JS. Self-replication and scrapie. Nature 1968; 215: 1043-1044.
66. Guichard C, Ivanyi-Nagy R, Sharma KK, Gabus C, Marc D, Mély Y, Darlix JL. Analysis of nucleic acid chaperoning by the prion protein and its inhibition by oligonucleotides. Nucleic Acids Res 2011; 39: 8544-8558.
67. Hope J. The nature of the scrapie agent: the evolution of the virino. In: Björnsson J, Carp RI, Löve A,Wisniewski HM (eds.). Slow Infections of the central nervous system. The legacy of Dr. Björn Sigurdsson. The New York Academy of Sciences, New York 1994; pp. 282-289.
68. Hsiao KK, Groth D, Scott M, Yang SL, Serban H, Rapp D, Foster D, Torchia M, Dearmond SJ, Prusiner SB. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A 1994; 91: 9126-9130.
69. Hsiao K, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990; 250: 1587-1590. (Pubitemid 120034374)
70. Hunter GD. Scrapie and Mad Cow Disease. The Smallest and Most Lethal Thing. Vantage Press, New York 1993.
71. Hunter GD, Collis SC, Milson GC, Kimberlin RH. Search for scrapie-specific RNA and attempts to detect an infectious DNA or RNA. J Gen Virol 1976; 32: 157-162.
72. Hunter GD, Millson GC. Distribution and activation of lysosomal enzyme activities in subcellular components of normal and scrapie-affected mouse brain. J Neuroch 1966; 13: 375-383.
73. Hunter GD, Kimberlin RH, Gibbons RA. Scrapie: amodified membrane hypothesis. J Theoret Biol 1968; 20: 235-357.
74. Jeffrey M, Wells GAH. Spongiform encephalopathy in a Nyala (Tragelaphus angasi). Vet Pathol 1988; 25: 398-399.
75. Karapetyan Y. Long double stranded RNA is present in scrapie infected cells and tissues; available from Nature Precedings: http://dx.doi.org/10.1038/ npre.2012.6759.1 (2012).
76. Kellings K, Meyer N, Mirenda C, Prusiner SB, Riesner D. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J Gen Virol 1992; 73: 1025-1029.
77. Kimberlin RH, Walker CA. Characteristics of a short incubation model of scrapie in the Golden hamsters. J Gen Virol 1977; 34: 295-304. (Pubitemid 8028621)
78. Kimberlin RH, Walker CA. Evidence that the transmission of one source of scrapie agent to hamsters involve separation of agent strains from a mixture. J Gen Virol 1978; 39: 487-496. (Pubitemid 8337652)
79. Kirkwood JK, Wells GAH, Cunningham AA, Jackson SI, Scott AC, Dawson M, Wilesmith JW. Scrapie-like encephalopathy in a greater kudu (Tragelaphus strepsiceros) which had not beed fed ruminant-derived protein. Vet Res 1992; 130: 365-367.
80. Levine P. Scrapie: an infective polypeptide? Lancet 1972; 1: 748.
81. Liberski PP. Kuru and D. Carleton Gajdusek: a close encounter. Folia Neuropathol 2009; 47: 114-137.
82. Liberski PP. Prion diseases: a riddle wrapped in amystery inside an enigma. Folia Neuropathol 2008; 46: 93-116.
83. Liberski PP, Brown P. Disease-specific particles without prion protein in prion diseases - phenomenon or epiphenomenon? Neuropathol Appl Neurobiol 2007; 33: 395-397. (Pubitemid 47037895)
84. Liberski PP, Sikorska B, Hauw JJ, Kopp N, Streichenberger N, Giraud P, Budka H, Boellaard JW, Brown P. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases. Virus Res 2008; 132: 226-228.
85. Liberski PP, Sikorska B, Lindenbaum S, Goldfarb LG, McLean C, Hainfellner JA, Brown P. Kuru: genes, cannibals and neuro pathology. J Neuropathol Ex Nneurol 2012; 71: 92-103.
86. M'Gowan JP: Investigation into the disease of sheep called "scrapie" (Traberkrankheit, La tremblante). With especial reference to its association with Sarcosporidiosis. William Blackwood and Sons, Edinburgh 1914.
87. Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV. Genesis of Mammalian Prions: From Noninfectious Amyloid Fibrils to a Transmissible Prion Disease. PLoS Pathog 2011; 7: e1002419.
88. Malone TG, Marsh RF, Hanson RP. Evidence for the low mole cular weight nature of scrapie agent. Nature 1979; 278: 575-576. (Pubitemid 9146528)
89. Malone TG, Marsh RF, Hanson RP, Semancik JS. Membrane-free scrapie infectivity. J Virol 1978; 25: 933-935.
90. Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, Somerville R, Ironside J, Will R, Sy MS, Melton DW, Hope J, Bostock C. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 1999; 18: 6855-6864.
91. Manuelidis L. The dimension of Creutzfeldt-Jakob disease. Transfusion 1994; 34: 915-927.
92. Marsh RF. The scrapie agent. In: Semancik JS (ed.). Viroids and Viroid-like Pathogens. CRC Press, Boca Raton 1977; pp. 161-168.
93. Marsh RF, Malone TG, Lancaster WD, Hanson RP, Semancik JS. Scrapie: virus, viroid, or voodoo? In: Persistent Viruses. Academic Press, New York 1978; pp. 581-590.
94. Marsh RF, Malone TG, Semancik J, Lancaster WD, Hanson RP. Evidence for an essential DNA component in the scrapie agent. Nature 1978; 275: 146-147. (Pubitemid 9006946)
95. Marsh RF, Semancik JS, Medappa KC, Hanson RP, Rueckert RR. Scrapie and transmissible mink enecphalopathy: serach for infectious nucleic acid. J Virol 1974; 13: 993-996.
96. Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus induced spongiform encephalopathies. Brain 1981; 104: 559-588. (Pubitemid 12202196)
97. McKinley MP, Bolton DC, Prusiner SB. A protease resistant protein is a structural component of the scrapie prion. Cell 1983; 35: 57-62. (Pubitemid 14240218)
98. Medori R, Montagna P, Tritschler H-J, LeBlanc A, Cordelli P, Tinuper P, Lugaresi E, Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 1992; 42: 669-671.
99. Medori R, Tritschler H-J, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw JJ, Ott J, Lugaresi L, Autilio-Gambetti L, Gambetti P. Fatal familial insomnia, a prion disease with amutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326: 444-449.
100. Merz PA, Rohwer RG, Kascsak R, Wisniewski HM, Somerville RA, Gibbs CJ Jr, Gajdusek DC. Infection-specific particle from the unconventional slow virus diseases. Science 1984; 225: 437-440. (Pubitemid 14089451)
101. Merz PA, Somerville RA, Wisniewski HM, Manuelidis L, Manuelidis EE. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 1983; 306: 474-476. (Pubitemid 14235567)
102. Meyer N, Rosenbaum V, Schmidt B, Gilles K, Mirenda C, Groth D, Prusiner SB, Riesner D. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 1991; 72: 37-49.
103. Millson GC, Hunter GD, Kimberlin RH. The physico-chemical nature of the scrapie agent. In: Kimberlin RH (ed.). Slow Virus Diseases of Animals and Man. North-Holland Publ Comp, Amsterdam 1976; pp. 243-266.
104. Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, Melton DW, Manson JC. Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet 1998; 18: 118-125. (Pubitemid 28082457)
105. Morris J, Gajdusek DC. Encephalopathy in mice following inoculation of scrapie sheep brain. Nature 1963; 197: 1084-1086.
106. Parry HB. Scrapie: a transmissible and hereditary disease of sheep. Heredity 1962; 17: 75-105.
107. Pattison IH. A sideways look at scrapie saga: 1732-1991. In: Prusiner SB, Collinge J, Powell J, Anderton B (eds.). Prion diseases of humans and animals. Ellis Horwood, New York 1993; pp. 15-22.
108. Prusiner SB. Novel proteinaceous infection particles cause scrapie. Science 1982; 216: 136-144. (Pubitemid 12089840)
109. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE. Purification and structural studies of amajor scrapie prion protein. Cell 1984; 38: 127-134. (Pubitemid 15216542)
110. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloidlike birefringent rods. Cell 1983; 35: 349-358. (Pubitemid 14202913)
111. Roche-LubinM. Memoire practique sur la maladie des betes a laine connue sous les noms de prurigo-lombaire, convulsive, trembleuse, tremblante. Recueil Med Vet Pract 1848; 5: 698-714.
112. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA. AmiRNA signature of prion induced neurodegeneration. PLoS One 2008; 3: e3652.
113. Simoneau S, Ruchoux MM, Vignier N, Lebon P, Freire S, Comoy E, Deslys JP, Fournier JG. Small critical RNAs in the scrapie agent; available from Nature Precedings: http://hdl.handle.net/10101/npre. 2009.3344.1 (2009).
114. Sklaviadis T, Akowitz A, Manuelidis EE, Manuelidis L. Nucleid acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations. Proc Natl Acad Sci USA 1993; 90: 5713-5717. (Pubitemid 23176232)
115. Somerville RA, Oberthur RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. Characterisation of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J Biol Chem 2002; 277: 11084-11089. (Pubitemid 34952868)
116. Taruscio D, Manuelidis L. Integration site preferences of endogenous retroviruses. Chromosoma 1991; 101: 141-156.
117. Weissmann C. The state of prion. Nat Rev Microbiol 2004; 2: 861-871.
118. Wells GAH, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M, Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121: 419-420.
119. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang S-L, Torchia M, Carlson GA, Prusiner SB. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion protein. Cell 1994; 76: 117-129. (Pubitemid 24035286)
120. Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildlife Dis 1980; 16: 89-98.
121. Williams ES, Young S. Spongiform encephalopathy in a Rocky Mountain elk. J Wildlife Dis 1982; 18: 465-471.
122. Willoughby K, Kelly DF, Lyeon DG, Wells GAH. Spongiform encephalopathy in a captive puma (Felis concolor). Vet Res 1992; 131: 431-434.
123. Wilson DR, Ruth D, Anderson RD, Smith W. Studies in scrapie. J Comp Pathol 1950; 60: 267-282.
124. Wood JLN, Lund LJ, Done SH. The natural occurrence of scrapie in moufflon. Vet Rec 1991; 130: 25-27.
125. Wyatt JM, Pearson GR, Smerdon TN, Gruffydd-Jones TJ, Wells GA, Wilesmith JW. Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet Rec 1991; 129: 233-236.